Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
R Cowley Shock Trauma Hospital
mi
from
Baltimore, MD
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
R Cowley Shock Trauma Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Wayne State University - Sinai Grace Hospital
mi
from
Detroit, MI
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Wayne State University - Sinai Grace Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Baylor University Medical Center
mi
from
Dallas, TX
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
UT-Houston Health Science Center
mi
from
Houston, TX
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
UT-Houston Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
University of Virginia Medical Center
mi
from
Charlottesville, VA
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tucson, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Chino, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Fresno, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
National City, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
San Francisco, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Boulder, CO
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
DeLand, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Fort Meyers, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Miami, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Orlando, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tampa, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Idaho Falls, ID
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Meridan, ID
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Meridan, ID
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Lexington, KY
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Boston, MA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Kansas City, MO
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tulsa, OK
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Greer, SC
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Dallas, TX
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Houston, TX
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Norfolk, VA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status: Enrolling
Updated:  4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status: Enrolling
Updated: 4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Florida
mi
from
Gainesville, FL
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Georgia Health Sciences University
mi
from
Augusta, GA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Tulane University Health Science Center
mi
from
New Orleans, LA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Tulane University Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
University of Maryland School of Medicine
mi
from
Baltimore, MD
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Henry Ford Hospital
mi
from
Detroit, MI
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Montefiore Medical Center
mi
from
Bronx, NY
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Duke University
mi
from
Durham, NC
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated:  4/19/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Clarification of Optimal Anticoagulation Through Genetics
A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients
Status: Enrolling
Updated: 4/19/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials